Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.
Start price
08.03.23
/
50%
€19.83
Target price
08.03.24
€30.31
Performance (%)
7.94%
End price
09.03.24
€21.40
Summary
This prediction ended on 09.03.24 with a price of €21.40. With a performance of 7.94%, the BUY prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc. closed with a slight gain. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corcept Therapeutics Inc. | 8.665% | 8.665% | 30.446% |
| iShares Core DAX® | -0.683% | 1.890% | 15.367% |
| iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% |
| iShares Nikkei 225® | -1.486% | -2.361% | 7.668% |
| iShares S&P 500 | -0.523% | 2.324% | 25.460% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $33.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten